Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

04 avr. 2016 08h00 HE | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces the U.S. Commercial Launch of New Single-Dose, Preservative-Free Makena® (hydroxyprogesterone caproate injection)

WALTHAM, Mass., April 04, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the new single-dose, preservative-free Makena® is now available for prescribing....
16 mars 2016 07h00 HE | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces First Patient Enrolled in Head-to-Head Phase 3 Clinical Trial Evaluating Feraheme® in Adults With Iron Deficiency Anemia

Trial marks the final clinical milestone on the pathway to pursue a broader Feraheme® label WALTHAM, Mass., March 16, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)...
26 févr. 2016 08h15 HE | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Present at Upcoming Investor Conferences

WALTHAM, Mass., Feb. 26, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will discuss AMAG’s business and financial outlook, strategy and...
23 févr. 2016 12h46 HE | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces FDA Approval of New Single-Dose, Preservative-Free Makena® (hydroxyprogesterone caproate injection)

WALTHAM, Mass., Feb. 23, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s...
17 févr. 2016 07h00 HE | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial Results

Fourth quarter 2015 non-GAAP revenue up 137% to $120.6 million1Fourth quarter 2015 non-GAAP adjusted EBITDA increased 322% to $61.3 million1Conference call scheduled for 8:00 a.m. ET todayWALTHAM,...
04 févr. 2016 08h00 HE | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Host Conference Call on February 17, 2016 at 8:00 a.m. ET to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2015

WALTHAM, Mass., Feb. 04, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced it will report unaudited consolidated financial results for the fourth quarter and year...
02 févr. 2016 08h00 HE | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Present at Upcoming Investor Conferences

WALTHAM, Mass., Feb. 02, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will discuss AMAG’s business and financial outlook, strategy and...
11 janv. 2016 08h00 HE | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Preliminary 2015 Financial Results and Provides 2016 Financial Guidance

Achieves record 2015 annual Feraheme® and Makena® product sales: Makena grows approximately 52% over 2014Two maternal health transactions in 2015 to bolster future revenue growth and...
06 janv. 2016 08h00 HE | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces $60 Million Share Repurchase Program

WALTHAM, Mass., Jan. 06, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that its Board of Directors has approved a share repurchase program under which AMAG...
05 janv. 2016 08h00 HE | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. to Present at the 34th Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Jan. 05, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that William Heiden, AMAG’s chief executive officer, will present at the 34th Annual...

Page précédente